The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer‘s Disease
Abstract
Alzheimer's disease (AD) is an aging-related multi-factorial disorder to which metabolic factors contribute at what has canonically been considered a centrally mediated process. Although the exact underlying mechanisms are still unknown, obesity is recognized as a risk factor for AD and the condition of insulin resistance seems to be the link between the two pathologies. Using mice with high fat diet (HFD) obesity we dissected the molecular mechanisms shared by the two disorders. Brains of HFD fed mice showed elevated levels of APP and Aβ40/Aβ42 together with BACE, GSK3β and Tau proteins involved in APP processing and Aβ accumulation. Immunofluorescence, Thioflavin T staining experiments, confirmed increased Aβ generation, deposition in insoluble fraction and plaques formation in both the hippocampus and the cerebral cortex of HFD mice. Presence of Aβ40/Aβ42 in the insoluble fraction was also shown by ELISA assay. Brain insulin resistance was demonstrated by reduced presence of insulin receptor (IRs) and defects in Akt-Foxo3a insulin signaling. We found reduced levels of phospho-Akt and increased levels of Foxo3a in the nuclei of neurons where proapototic genes were activated. Dysregulation of different genes related to insulin resistance, especially those involved in inflammation and adipocytokines synthesis were analyzed by Profiler PCR array. Further, HFD induced oxidative stress, mitochondrial dysfunction and dynamics as demonstrated by expression of biomarkers involved in these processes. Here, we provide evidence that obesity and AD markers besides insulin resistance are associated with inflammation, adipokine dyshomeostasis, oxidative stress and mitochondrial dysfunction, all mechanisms leading to neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent study showed that insulin resistance secondary to a high-fat diet leads to increased levels of oxidative stress, which contributes to neurodegeneration in AD [44].”
From Oxidative Stress and Ageing: The Influence of Environmental Pollution, Sunlight and Diet on Skin (2017) · cites this paper as [44]
Citations
Cites
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,345
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
Craft, S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.233 · Cited by 1,253
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Wang, X., Su, B., Lee, H.-G., Li, X., Perry, G., Smith, M. A., & Zhu, X. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1357-09.2009 · Cited by 1,224
Molteni, R., Barnard, R. J., Ying, Z., Roberts, C. K., & Gómez‐Pinilla, F. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00123-9 · Cited by 918
Wang, X., Su, B., Siedlak, S. L., Moreira, P. I., Fujioka, H., Wang, Y., Casadesus, G., & Zhu, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804871105 · Cited by 835
Midlife and Late-Life Obesity and the Risk of Dementia: Cardiovascular Health Study
Fitzpatrick, A. L., Kuller, L. H., Lopez, O. L., Diehr, P., O’Meara, E. S., Longstreth, W. T., & Luchsinger, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.582 · Cited by 796
De Felice, F. G., Vieira, M. N. N., Bomfim, T. R., Decker, H., Velasco, P. T., Lambert, M. P., Viola, K. L., Zhao, W.-Q., Ferreira, S. T., & Klein, W. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809158106 · Cited by 657
Jheng, H.-F., Tsai, P.-J., Guo, S.-M., Kuo, L.-H., Chang, C.-S., Su, I.-J., Chang, C.-R., & Tsai, Y.-S. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05603-11 · Cited by 650
Ho, L., Qin, W., Pompl, P. N., Xiang, Z., Wang, J., Zhao, Z., Peng, Y., Cambareri, G. M., Rocher, A. B., Mobbs, C. V., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0978fje · Cited by 640
Amyloid beta oligomers induce impairment of neuronal insulin receptors
Zhao, W., De Felice, F. G., Fernandez, S., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., & Klein, W. L. (2008) · The FASEB Journal · doi:10.1096/fj.06-7703com · Cited by 587
Beydoun, M. A., Beydoun, H. A., & Wang, Y. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00473.x · Cited by 563
The Alzheimer's disease Beta-secretase enzyme, BACE1
Cole, S. L., & Vassar, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-22 · Cited by 550
Brain metabolic dysfunction at the core of Alzheimer's disease
de la Monte, S. M., & Tong, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.012 · Cited by 472
Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain Aging
Lieb, W. (2009) · JAMA · doi:10.1001/jama.2009.1836 · Cited by 428
The Role of Insulin Resistance in the Pathogenesis of Alzheimer??s Disease
Watson, G. S., & Craft, S. (2003) · CNS Drugs · doi:10.2165/00023210-200317010-00003 · Cited by 400
Nitric oxide and neuronal death
Brown, G. C. (2010) · Nitric Oxide · doi:10.1016/j.niox.2010.06.001 · Cited by 396
Gunstad, J., Lhotsky, A., Wendell, C. R., Ferrucci, L., & Zonderman, A. B. (2010) · Neuroepidemiology · doi:10.1159/000297742 · Cited by 369
Manczak, M., & Reddy, P. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds360 · Cited by 348
Fat intake at midlife and cognitive impairment later in life: a population‐based CAIDE study
Eskelinen, M. H., Ngandu, T., Helkala, E., Tuomilehto, J., Nissinen, A., Soininen, H., & Kivipelto, M. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1969 · Cited by 321
Obesity‐related leptin regulates Alzheimer's Aβ
Fewlass, D. C., Noboa, K., Pi‐Sunyer, F. X., Johnston, J. M., Yan, S. D., & Tezapsidis, N. (2004) · The FASEB Journal · doi:10.1096/fj.04-2572com · Cited by 308
Insulin in the Brain: Sources, Localization and Functions
Ghasemi, R., Haeri, A., Dargahi, L., Mohamed, Z., & Ahmadiani, A. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8339-9 · Cited by 308
Modulation of memory by insulin and glucose: Neuropsychological observations in Alzheimer’s disease
Watson, G. S., & Craft, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.048 · Cited by 307
Marks, D. R., Tucker, K., Cavallin, M. A., Mast, T. G., & Fadool, D. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1350-09.2009 · Cited by 242
Relationship between body mass index and brain volume in healthy adults
Gunstad, J., Paul, R. H., Cohen, R. A., Tate, D. F., Spitznagel, M. B., Grieve, S., & Gordon, E. (2008) · International Journal of Neuroscience · doi:10.1080/00207450701392282 · Cited by 216
Orexin-A (Hypocretin-1) and leptin enhance LTP in the dentate gyrus of rats in vivo
Wayner, M. J., Armstrong, D. L., Phelix, C. F., & Oomura, Y. (2004) · Peptides · doi:10.1016/j.peptides.2004.03.018 · Cited by 190
Heyward, F. D., Walton, R. G., Carle, M. S., Coleman, M. A., Garvey, W. T., & Sweatt, J. D. (2012) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2012.04.005 · Cited by 180
High-fat diets impair spatial learning in the radial-arm maze in mice
Valladolid‐Acebes, I., Stucchi, P., Cano, V., Fernández‐Alfonso, M. S., Merino, B., Gil‐Ortega, M., Fole, A., Morales, L., Ruiz‐Gayo, M., & Olmo, N. D. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.11.007 · Cited by 160
Hsp60 chaperonopathies and chaperonotherapy: targets and agents
Cappello, F., Marino, A., Piccionello, A. P., Campanella, C., Pace, A., de Macario, E. C., & Macario, A. J. L. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.856417 · Cited by 149
Reddy, P. H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.06.012 · Cited by 147
THE GENETICS AND MOLECULAR PATHOLOGY OF ALZHEIMER'S DISEASE
Selkoe, D. J. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70232-2 · Cited by 146
Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease
Teixeira, A. L., Diniz, B. S., Campos, A. C., de Miranda, A. S., Rocha, N. P., Talib, L. L., Gattaz, W. F., & Forlenza, O. V. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8201-2 · Cited by 138
Takeda, S., Sato, N., Ikimura, K., Nishino, H., Rakugi, H., & Morishita, R. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.010 · Cited by 135 · cited 3×
“They can cross the BBB, and can therefore exert a neuroprotective role on cognitionrelated structures [50].”
BackgroundLeptin regulation of Hsp60 impacts hypothalamic insulin signaling
Kleinridders, A., Lauritzen, H. P. M. M., Ussar, S., Christensen, J. H., Mori, M. A., Bross, P., & Kahn, C. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67615 · Cited by 130
Leptin inhibits glycogen synthase kinase-3β to prevent tau phosphorylation in neuronal cells
Greco, S. J., Sarkar, S., Casadesús, G., Zhu, X., Smith, M. A., Ashford, J. W., Johnston, J. M., & Tezapsidis, N. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.066 · Cited by 119
Qin, W., Zhao, W., Ho, L., Wang, J., Walsh, K. X., Gandy, S., & Pasinetti, G. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.024 · Cited by 113
Central Proliferation and Neurogenesis Is Impaired in Type 2 Diabetes and Prediabetes Animal Models
Ramos‐Rodríguez, J. J., Gil, S. M., Ortiz-Barajas, O., Jiménez-Palomares, M., Perdomo, G., Cózar‐Castellano, I., Lechuga-Sancho, A. M., & García-Alloza, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089229 · Cited by 105
Amyloid Precursor Protein Expression Is Upregulated in Adipocytes in Obesity
Lee, Y., Tharp, W. G., Maple, R. L., Nair, S., Permana, P. A., & Pratley, R. E. (2008) · Obesity · doi:10.1038/oby.2008.267 · Cited by 104
Mastrangelo, M. A., Sudol, K. L., Narrow, W. C., & Bowers, W. J. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090059 · Cited by 100
Obesity as a risk factor for Alzheimer’s disease: the role of adipocytokines
Letra, L., Santana, I. J., & Seiça, R. M. F. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9501-z · Cited by 92
An Integrated and Unifying Hypothesis for the Metabolic Basis of Sporadic Alzheimer's Disease
Erol, A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13302 · Cited by 89
Nickl‐Jockschat, T., Kleiman, A., Schulz, J. B., Schneider, F. W., Laird, A. R., Fox, P. T., Eickhoff, S. B., & Reetz, K. (2011) · Brain Structure and Function · doi:10.1007/s00429-011-0333-x · Cited by 86
Obesity, Insulin Resistance, and Alzheimer's Disease
Hildreth, K. L., Van Pelt, R. E., & Schwartz, R. S. (2012) · Obesity · doi:10.1038/oby.2012.19 · Cited by 86
Lee, Y., Martin, J., Maple, R. L., Tharp, W. G., & Pratley, R. E. (2009) · Neuroendocrinology · doi:10.1159/000235555 · Cited by 69
Marino, A., Rizzo, M., Citarrella, R., Rappa, F., Campanella, C., Bucchieri, F., Patti, A. M., Nikolić, D., Cabibi, D., Amico, G., et al. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0460-9 · Cited by 69
Picone, P., Giacomazza, D., Vetri, V., Carrotta, R., Militello, V., Biagio, P. L. S., & Carlo, M. D. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00724.x · Cited by 67
Bidirectional metabolic regulation of neurocognitive function
Stranahan, A. M., & Mattson, M. P. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.01.004 · Cited by 62
Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet
Baldassano, S., Amato, A., Cappello, F., Rappa, F., & Mulè, F. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0500 · Cited by 60
Adiposity hormones and dementia
Gustafson, D. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.036 · Cited by 58
Pedrini, S., Thomas, C., Brautigam, H., Schmeidler, J., Ho, L., Fraser, P., Westaway, D. A., George‐Hyslop, P. S., Martins, R. N., Buxbaum, J. D., et al. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-40 · Cited by 50
Hsp60 response in experimental and human temporal lobe epilepsy
Marino, A., Colangeli, R., Orbán, G., Pierucci, M., Gennaro, G. D., Bello, M. L., D’Aniello, A., Bucchieri, F., Pomara, C., Valentino, M., et al. (2015) · Scientific Reports · doi:10.1038/srep09434 · Cited by 38
Resistin protection against endogenous Aβ neuronal cytotoxicity from mitochondrial pathway
Liu, J., Chi, N., Chen, H., Zhang, J., Bian, Y., Cui, G., & Xiu, C. (2013) · Brain Research · doi:10.1016/j.brainres.2013.05.041 · Cited by 27
Obesity-Associated Cognitive Decline: Excess Weight Affects More than the Waistline
Cohen, R. A. (2010) · Neuroepidemiology · doi:10.1159/000297745 · Cited by 25
Arvanitidis, A. P., Corbett, D., & Colbourne, F. (2008) · Brain Research · doi:10.1016/j.brainres.2008.11.058 · Cited by 23
Genes and obesity: A cause and effect relationship
Jiménez, E. G. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2011.06.005 · Cited by 20
Cited by
Sorted by citations
An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus
Heydemann, A. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2902351 · Cited by 392
Therapies for Prevention and Treatment of Alzheimer’s Disease
Mendiola-Precoma, J., Berumen, L. C., Padilla, K., & García‐Alcocer, G. (2016) · BioMed Research International · doi:10.1155/2016/2589276 · Cited by 262
Spinelli, M., Fusco, S., Mainardi, M., Scala, F., Natale, F., Lapenta, R., Mattera, A., Rinaudo, M., Puma, D. D. L., Ripoli, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02221-9 · Cited by 213
Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
Al-Ghraiybah, N. F., Wang, J., Alkhalifa, A. E., Roberts, A. B., Raj, R., Yang, E., & Kaddoumi, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810572 · Cited by 217
Sripetchwandee, J., Chattipakorn, N., & Chattipakorn, S. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00496 · Cited by 199
Metadata
- Authors
- Nuzzo, D., Picone, P., Baldassano, S., Caruana, L., Messina, E., Gammazza, A., Cappello, F., Mulè, F., & Carlo, M.
- Affiliations
- National Research Council (IT)
- Istituto di Biomedicina e di Immunologia Molecolare Alberto Monroy (IT)
- ORCID
- Venue
- Current Alzheimer Research
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2015-09-11
- Volume
- 12
- Issue
- 8
- Pages
- 723-735
- ISSN
- 1567-2050 (ISSN-L)
- OpenAlex
- W831032665
- Cited by
- 119
- References
- 60
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 9 · 2023: 9 · 2022: 11 · 2021: 6 · 2020: 13 · 2019: 19 · 2018: 15 · 2017: 10 · 2016: 16 · 2015: 1
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Alzheimer Research (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- insulin resistance, Alzheimer's disease, obesity, high-fat diet, amyloid-beta, APP processing, BACE, GSK3β, tau protein, insulin receptor, neuroinflammation, adipokines, oxidative stress, mitochondrial dysfunction, neurodegeneration, amyloid plaques
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Alzheimer Disease, Animals, Brain, Disease Models, Animal, Gene Expression Regulation, Insulin, Insulin Resistance, Male, Mice, Inbred C57BL, Obesity, Receptor, Insulin, Time Factors, Signal Transduction, Case-Control Studies, Cytokines, Oxidative Stress, Glycogen Synthase Kinase 3, Mice, Amyloid Precursor Protein Secretases, Amyloidogenic Proteins, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review